167 related articles for article (PubMed ID: 24442863)
1. Effects of pyrophosphate delivery in a peritoneal dialysis solution on bone tissue of apolipoprotein-E knockout mice with chronic kidney disease.
Barreto FC; de Oliveira RB; Benchitrit J; Louvet L; Rezg R; Poirot S; Jorgetti V; Drüeke TB; Riser BL; Massy ZA
J Bone Miner Metab; 2014 Nov; 32(6):636-44. PubMed ID: 24442863
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal delivery of sodium pyrophosphate blocks the progression of pre-existing vascular calcification in uremic apolipoprotein-E knockout mice.
de Oliveira RB; Louvet L; Riser BL; Barreto FC; Benchitrit J; Rezg R; Poirot S; Jorgetti V; Drüeke TB; Massy ZA
Calcif Tissue Int; 2015 Aug; 97(2):179-92. PubMed ID: 26087714
[TBL] [Abstract][Full Text] [Related]
3. Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia.
Riser BL; Barreto FC; Rezg R; Valaitis PW; Cook CS; White JA; Gass JH; Maizel J; Louvet L; Drueke TB; Holmes CJ; Massy ZA
Nephrol Dial Transplant; 2011 Oct; 26(10):3349-57. PubMed ID: 21398365
[TBL] [Abstract][Full Text] [Related]
4. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure.
Nikolov IG; Joki N; Nguyen-Khoa T; Ivanovski O; Phan O; Lacour B; Drüeke TB; Massy ZA; Dos Reis LM; Jorgetti V; Lafage-Proust MH
Bone; 2010 Jul; 47(1):156-63. PubMed ID: 20406703
[TBL] [Abstract][Full Text] [Related]
6. Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease?
Neven E; Opdebeeck B; De Maré A; Bashir-Dar R; Dams G; Marynissen R; Behets GJ; Verhulst A; Riser BL; D'Haese PC
Calcif Tissue Int; 2016 Nov; 99(5):525-534. PubMed ID: 27461215
[TBL] [Abstract][Full Text] [Related]
7. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
Williams MJ; Sugatani T; Agapova OA; Fang Y; Gaut JP; Faugere MC; Malluche HH; Hruska KA
Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411
[TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.
Belmokhtar K; Ortillon J; Jaisson S; Massy ZA; Boulagnon Rombi C; Doué M; Maurice P; Fritz G; Gillery P; Schmidt AM; Rieu P; Touré F
Nephrol Dial Transplant; 2019 Dec; 34(12):2018-2030. PubMed ID: 30778553
[TBL] [Abstract][Full Text] [Related]
9. Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease.
Ruderman I; Hewitson TD; Smith ER; Holt SG; Wigg B; Toussaint ND
BMC Nephrol; 2020 Jul; 21(1):279. PubMed ID: 32677907
[TBL] [Abstract][Full Text] [Related]
10. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
[TBL] [Abstract][Full Text] [Related]
11. Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
Sugatani T; Agapova OA; Fang Y; Berman AG; Wallace JM; Malluche HH; Faugere MC; Smith W; Sung V; Hruska KA
Kidney Int; 2017 Jan; 91(1):86-95. PubMed ID: 27666759
[TBL] [Abstract][Full Text] [Related]
12. Pyrophosphate deficiency in vascular calcification.
Villa-Bellosta R; O'Neill WC
Kidney Int; 2018 Jun; 93(6):1293-1297. PubMed ID: 29580636
[TBL] [Abstract][Full Text] [Related]
13. Role of pyrophosphate in vascular calcification in chronic kidney disease.
Azpiazu D; Gonzalo S; González-Parra E; Egido J; Villa-Bellosta R
Nefrologia (Engl Ed); 2018; 38(3):250-257. PubMed ID: 29137892
[TBL] [Abstract][Full Text] [Related]
14. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.
Jovanovich A; Isakova T; Block G; Stubbs J; Smits G; Chonchol M; Miyazaki M
Am J Kidney Dis; 2018 Jan; 71(1):27-34. PubMed ID: 28801122
[TBL] [Abstract][Full Text] [Related]
15. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
Nikolov IG; Joki N; Nguyen-Khoa T; Guerrera IC; Maizel J; Benchitrit J; Machado dos Reis L; Edelman A; Lacour B; Jorgetti V; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2012 Feb; 27(2):505-13. PubMed ID: 21705467
[TBL] [Abstract][Full Text] [Related]
16. Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression.
Chen B; Zhao Y; Han D; Zhao B; Mao Y; Cui ZK; Chu YC; Feng L; Yin S; Wang CY; Wang X; Xu MJ; Zhao G
J Mol Cell Cardiol; 2019 Oct; 135():10-21. PubMed ID: 31356809
[TBL] [Abstract][Full Text] [Related]
17. Vascular calcification inhibitors and cardiovascular events in peritoneal dialysis patients.
Olmaz R; Selen T; Gungor O
Ther Apher Dial; 2024 Apr; 28(2):169-181. PubMed ID: 38013624
[TBL] [Abstract][Full Text] [Related]
18. Plasma pyrophosphate and vascular calcification in chronic kidney disease.
O'Neill WC; Sigrist MK; McIntyre CW
Nephrol Dial Transplant; 2010 Jan; 25(1):187-91. PubMed ID: 19633093
[TBL] [Abstract][Full Text] [Related]
19. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
[TBL] [Abstract][Full Text] [Related]
20. Chronic Kidney Disease-Mineral Bone Disorder in the Elderly Peritoneal Dialysis Patient.
Heaf JG
Perit Dial Int; 2015 Nov; 35(6):640-4. PubMed ID: 26702005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
